Hanne Damgaard Jensen

Geschäftsführer bei CURASIGHT A/S

Vermögen: 5 605 $ am 31.05.2024

Health Technology

Consumer Services

Aktive Beziehungen

Name	Geschlecht	Alter	Unternehmensverbindungen	Zusammenarbeit
Jan van de Winkel	M	63	GENMAB A/S	25 Jahre
Andreas Kjaer	M	61	CURASIGHT A/S	11 Jahre
Ulrich Krasilnikoff	M	57	CURASIGHT A/S	8 Jahre
Carsten Nielsen	M	41	CURASIGHT A/S	11 Jahre
Per Falholt	M	65	CURASIGHT A/S	4 Jahre
Jacob Madsen	M	52	CURASIGHT A/S	11 Jahre
Henrik Ehlers Wulff	M	54	NOVO NORDISK A/S	25 Jahre
Karsten Munk Knudsen	M	53	NOVO NORDISK A/S	25 Jahre
Charlotte Vedel	M	56	CURASIGHT A/S	4 Jahre
Anthony Pagano	M	46	GENMAB A/S	17 Jahre
Lars Trolle	M	57	CURASIGHT A/S	10 Jahre
Martine van Vugt	M	71	GENMAB A/S	23 Jahre
Camilla Sylvest	F	52	NOVO NORDISK A/S	28 Jahre
Anders Gersel Pedersen	M	73	GENMAB A/S	21 Jahre
Birgitte Stephensen	F	63	GENMAB A/S	22 Jahre
Kirsten Drejer	M	68	CURASIGHT A/S	3 Jahre
Nic Gillings	M	56	CURASIGHT A/S	-

Mehr sehen

Beziehungs-Chart

Beziehungen zu mehreren Unternehmen

Ehemalige Beziehungen

Name	Geschlecht	Alter	Unternehmensverbindungen	Zusammenarbeit
Michael Blair Widmer	M	76	GENMAB A/S	11 Jahre
Bo Kruse	M	52	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark. GENMAB A/S	15 Jahre
Jakob Riis	M	58	NOVO NORDISK A/S	21 Jahre
Claus Juan Møller-San Pedro	M	62	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark. GENMAB A/S	21 Jahre
Ole Baadsgaard	M	72	GENMAB A/S	-
Christina Hahner	F	-	GENMAB A/S	-
Jesper Brandgaard	M	60	NOVO NORDISK A/S	20 Jahre
Karsten Havkrog Pedersen	M	74	GENMAB A/S	11 Jahre
David Kauffmann	M	-	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	5 Jahre
Burt Malkiel	M	90	GENMAB A/S	11 Jahre
Tom Vink	M	61	GENMAB A/S	-
Nedjad Losic	M	55	GENMAB A/S	-
Lisa N. Drakeman	M	70	GENMAB A/S	11 Jahre
Michael K. Bauer	M	60	GENMAB A/S	14 Jahre
Hans Henrik Munch-Jensen	M	64	GENMAB A/S	8 Jahre
Patrick Loustau	M	61	NOVO NORDISK A/S	14 Jahre
Christopher Yallop	M	-	NOVO NORDISK A/S	6 Jahre
Henrik Poulsen	M	57	NOVO NORDISK A/S	1 Jahre
Martin Olin	M	55	NOVO NORDISK A/S	4 Jahre
Per Gullestrup	M	-	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	9 Jahre
Jan Mikkelsen	M	65	NOVO NORDISK A/S	11 Jahre
Jens Munch-Hansen	M	69	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	9 Jahre
Annette Stube	F	57	NOVO NORDISK A/S	11 Jahre
René Djurup	M	-	NOVO NORDISK A/S	4 Jahre
Rikke Glahn Ren	F	-	GENMAB A/S	-
Jorgen Petersen	M	-	GENMAB A/S	-
Patrick van Berkel	M	55	GENMAB A/S	9 Jahre
Anna Héléne Barnekow	F	60	NOVO NORDISK A/S	2 Jahre
Gitte L. Pedersen	F	61	NOVO NORDISK A/S	10 Jahre
Zaiton binti Jamaluddin	F	65	NOVO NORDISK A/S	8 Jahre
Wolfgang Amann	M	-	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	-
Peter Nordkild	M	69	NOVO NORDISK A/S	2 Jahre
Joseph Fred Yospe	M	66	GENMAB A/S	2 Jahre
Paul W. H. I. Parren	M	60	GENMAB A/S	16 Jahre
Christian Hansen	M	58	NOVO NORDISK A/S	7 Jahre
Anker Gunvald Lundemose	M	63	NOVO NORDISK A/S	4 Jahre
Peter David Suzdak	M	65	NOVO NORDISK A/S	7 Jahre
Donald Lee Drakeman	M	70	GENMAB A/S	-
Jan Ulf Sigvar J. Johansson	M	79	NOVO NORDISK A/S	7 Jahre
Bruce Carter	M	80	NOVO NORDISK A/S	4 Jahre
Jan Öhrström	M	67	NOVO NORDISK A/S	9 Jahre
Peter James Arthur Benson	M	69	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	2 Jahre
Bo Jesper Hansen	M	66	Azanta A/S Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.	5 Jahre
Christian Gröndahl	M	60	NOVO NORDISK A/S	14 Jahre
Annarie Lyles	M	63	GENMAB A/S	-
Florian Schönharting	M	55	GENMAB A/S	-
Jens Jesper Ovesen	M	67	NOVO NORDISK A/S	4 Jahre
Finn M. Ulrich	M	-	NOVO NORDISK A/S	8 Jahre
Per Toft Valstorp	M	75	NOVO NORDISK A/S	14 Jahre
Michael Wolff Jensen	M	53	GENMAB A/S	3 Jahre
Thomas Feldthus	M	64	NOVO NORDISK A/S	3 Jahre
Valeta A. Gregg	M	72	NOVO NORDISK A/S	5 Jahre
Peder Holk Nielsen	M	67	NOVO NORDISK A/S	5 Jahre
Jette Traulsen	M	-	NOVO NORDISK A/S	5 Jahre
Joan Schmidt	F	60	NOVO NORDISK A/S	20 Jahre

Statistik

Land	Beziehungen	% des Gesamten
Dänemark	72	100,00%

Alter der Beziehungen

Aktive

Vergangene

Herr

Frau

Aufsichtsräte

Führungskräfte

Ursprung der Beziehungen